Zynerba Pharmaceuticals Inc. (ZYNE) declined -10.75% or -0.69 to $5.73. It is nearly 1.21 million shares traded, which is 208.91% compare to the average total volume 578530. The market cap of ZYNE is $77.71 million. The year to date change is -61.34%. The 52 week price range is from $5.42 to $15.59. Price of ZYNE have changed -10.83% during last week. It have changed -33.81% over last month, -38.33% over last 3 months, -45.91% over last 6 months and -57.37% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 10.00. It is 74.52% above current price. The 200-day Moving Averages for ZYNE is 10.65. It is 85.86% above current price. The 52-week High is 15.59. It is 172.08% from the current price. The 52-week Low is 5.42. It is -5.41% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 5.89 on 2018-07-13. Short % to float is 20.18%. There are some statistics of ZYNE. It is has market cap $77.71 million. The share outstanding is 13.56 million. The average volume is 578530. The percent of top 15 Institution holding is 25.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -57.86%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -51.26%.